Cargando…
Eczematous reaction to IVIG for the treatment of dermatomyositis()()
The use of high-dose intravenous immunoglobulin (IVIG) is an accepted therapy for patients with refractory dermatomyositis. Cases of eczematous reactions to IVIG have been reported in the literature, but to our knowledge, none in patients being treated for dermatomyositis. We report on the cases of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116829/ https://www.ncbi.nlm.nih.gov/pubmed/30175220 http://dx.doi.org/10.1016/j.ijwd.2018.03.004 |